Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice: Analysis of cytokine mRNA expression in the graft

Transplantation

Volumn 60, Issue 4, 1995, Pages 368-374

  Rabinovitch, Alex ^a   Suarez Pinzon, Wilma L ^a   Sorensen, Ole ^a   Chris Bleackley, R ^a   Power, Robert F ^a   Rajotte, Ray V ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECURRENCE RISK; SURGERY;

ANIMAL; BASE SEQUENCE; CYTOKINES; DIABETES MELLITUS, INSULIN-DEPENDENT; DNA PRIMERS; DRUG THERAPY, COMBINATION; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; RECURRENCE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TH1 CELLS; TH2 CELLS;

EID: 0029091751     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199508270-00012     Document Type: Article

References (66)

1. Castano L, Eisenbarth GS. Type-I diabetes: a chronic autoim mune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8: 647.
2. Rossini AA, Greiner DL, Friedman HP, Mordes JP. Immuno-pathogenesis of diabetes mellitus. Diabetes Rev 1993; 1: 43.
3. Gepts W, In't Veld PA. Islet morphologic changes. Diabetes Metab Rev 1987; 3: 859.
4. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267.
5. Sibley RK, Sutherland DER, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso-and allograft. Lab Invest 1985; 53: 132.
6. Santamaria P, Nakhleh RE, Sutherland DE, Barbosa JJ. Char acterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 1992; 41: 53.
7. Hännen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 1901.
8. Itoh N, Hanafusa T, Miyazaki A, et al. Mononuclear cell infil tration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993; 92: 2313.
9. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci USA 1991; 88: 527.
10. + T-cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 1992; 41: 998.
11. a donors. Diabetes 1993; 42: 44.
12. + T-cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes 1993; 42: 390.
13. Lee KU, Amano K, Yoon JY. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 1988; 37: 989.
14. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 1989; 32: 126.
15. Hutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S, Cooke A. Transfer of diabetes in mice prevented by blockade of adhe-sion-promoting receptor on macrophages. Nature 1990; 348: 639.
16. Ziegler A-G, Erhard J, Lampeter EF, Nagelkerken LM, Standi E. Involvement of dendritic cells in early insulitis of BB rats. J Autoimmunity 1992; 5: 571.
17. Mandrup-Poulsen T, Helqvist S, Wogensen LD, et al. Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 1990; 164: 169.
18. Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1993; 1: 215.
19. Corbett JA, McDaniel ML. Does nitric oxide mediate autoim mune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897.
20. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Genes encoding tumor necrosis factor a and granzyme A are expressed during developing of autoimmune diabetes. Proc Natl Acad Sci USA 1990; 87: 2239.
21. Young LHY, Peterson LB, Wicker LS, Pereschini PM, Young JD-E. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease: studies on spontaneous and adoptively transfered diabetes in nonobese diabetic mice. J Immunol 1989; 143: 3994.
22. Jiang Z, Makowiecki J, Mordes JP, Woda BA. Cytolysin gene expression in the islets of diabetic Biobreeding/Worcester rats. J Immunol 1994; 152: 322.
23. Mosmann TR, Coffman RL. TH1 and TH2 cells: different pat terns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
24. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993; 11: 29.
25. Moore KV, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin 10. Annu Rev Immunol 1993; 11: 165.
26. + T-cells. Annu Rev Immunol 1994; 12: 635.
27. Wang T, Singh B, Wamock GL, Rajotte RV. Prevention of recur rence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992; 41: 114.
28. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter KT. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294.
29. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496.
30. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleu kin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23: 2223.
31. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Im munol 1986; 136: 2348.
32. Parish CR. The relationship between humoral and cell-mediated immunity. Transplant Rev 1972; 13: 35.
33. Mosmann TR, Moore KW. The role of IL-10 in cross-regulation of Thl and Th2 responses. Immunol Today 1991; 12: A49.
34. Romagnani S. Lymphokine production by human T cells in dis ease states. Annu Rev Immunol 1994; 12: 227.
35. Wogensen L, Huang X, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175.
36. Wogensen L, Lee M-S, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379.
37. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. Transplantation 1992; 53: 1281.
38. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Ra-jotte RV, Bleackley RC. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 1994; 37: 833.
39. Shehadeh N, LaRosa F, Lafterty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmunity 1993; 6: 291.
40. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interfer-on-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133.
41. Campbell IL, Iscaro A, Harrison LC. IFN-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325.
42. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773.
43. Campbell IL, Kay TWH, Oxbrow L, Harrison LC. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991; 87: 739.
44. Debray-Sachs M, Camaud C, Boitard C, et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmunity 1991; 4: 237.
45. Nicoletti F, Meroni PL, Landolfo S, et al. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to in-feron-γ. Lancet 1990; 336: 319.
46. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB. Insulin-dependent diabetes in the NOD mouse model II: β-cell destruction in autoimmune diabetes is a TH2-and not a TH1-mediated event. Autoimmunity 1993; 15: 113.
47. Jiang Z, Edelmann L, Woda BA. Analysis of cytokine gene ex pression in the islets of the diabetic Biobreeding/Worcester rat utilizing the polymerase chain reaction. Diabetes 1992; 41 (suppl 1): 37A.
48. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (in-sulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 1991; 165: 97.
49. + islet-specific T-cell clone. Science 1990; 249: 1433.
50. Bergman B, Haskins K. Islet-specific T-cell clones from the NOD mouse respond to β-granule antigen. Diabetes 1994; 43: 197.
51. Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation cir cumvents diabetes in NOD/Lt mice. J Autoimmunity 1989; 2: 759.
52. Jacob CO, Asiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and inter-leukin-1. Proc Natl Acad Sci USA 1990; 87: 968.
53. Satoh J, Seino H, Abo T, et al. Recombinant human tumor necrosis factor-α suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345.
54. Zielasek J, Burkart V, Naylor P, Goldstein A, Kiesel U, Kolb H. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats. Immunology 1990; 69: 209.
55. Satoh J, Seino H, Shintani S, et al. Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α. J Immunol 1990; 145: 1395.
56. Gerasimidi A, Sheehan KCF, Schreiber RD, Lacy PE. Tumor necrosis factor α prevents rejection of islet xenografts (rat to mouse). Diabetes 1993; 42: 651.
57. Gordon C, Wofsy D. Effects of recombinant murine tumor necro sis factor-α on immune function. J Immunol 1990; 144: 1753.
58. Allison J, Oxbrow L, Miller JFAP. Consequences of in situ pro duction of IL-2 for islet cell death. Int Immunol 1994; 6: 541.
59. Higuchi Y, Herrera P, Muniesa P, et al. Expression of a tumor necrosis factor α transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 1992; 176: 1719.
60. Picarella DE, Kratz A, Li C-B, Ruddle NH, Flavell RA. Trans genic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. J Immunol 1993; 150: 4136.
61. Ohashi PS, Oehen S, Aichele P, et al. Induction of diabetes is influenced by the infectious virus and local expression of MHC class 1 and tumor necrosis factor-α. J Immunol 1993; 150: 5185.
62. Guerder S, Picarella DE, Linsley PS, Flavell RA. Costimulator B7-1 confers antigen-presenting cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 1994; 91: 5138.
63. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613.
64. Rapoport MJ, Jaramillo A, Zipris D, et al. IL-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice. J Exp Med 1993; 178: 87.
65. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant hu man IL-10 (rHU IL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin Immunol Immunopathol 1994; 71: 169.
66. Zurawski SM, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15: 15.